- Sterile Drug Products from Pharmakon Pharmaceuticals, Inc: CDER Statement - FDA alerts health care professionals not to use due to a lack of sterility assurance and other quality issues
Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death.Posted 04/16/2016
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Sunday, April 17, 2016
High Importance: Sterile Drug Products from Pharmakon Pharmaceuticals, Inc: CDER Statement - FDA alerts health care professionals not to use due to a lack of sterility assurance and other quality issues Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment